Immunohistochemistry for the detection of neural and inflammatory cells in equine brain tissue

Gretchen H Delcambre1, Junjie Liu2, Jenna M Herrington2

  • 1Department of Biomedical Sciencess/College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.

Peerj
|February 9, 2016
PubMed

Insights

This study developed new antibody protocols for equine infectious encephalitides research. These methods improve the characterization of immune cells in horse central nervous system tissues.

Area of Science:

  • Veterinary Pathology
  • Immunohistochemistry
  • Equine Neurology

Background:

  • Limited reagents hinder detailed analysis of equine infectious encephalitides' cellular responses in the central nervous system (CNS).
  • Characterizing peripheral and resident CNS cell populations is crucial for understanding neuroinflammation in horses.
  • Existing methods lack specificity for formalin-fixed, paraffin-embedded (FFPE) equine tissues.

Purpose of the Study:

  • To identify and optimize antibodies for immunohistochemistry (IHC) in equine CNS tissues.
  • To establish reliable protocols for phenotypic characterization of cellular responses in equine neuroinflammatory diseases.
  • To enable detailed investigation of immunopathology in horses.

Main Methods:

  • Screened various commercial and species-cross-reactive antibodies for manual IHC.
  • Optimized antigen retrieval (boiling in low pH citrate buffer), blocking, and detection systems for FFPE equine tissues.
  • Tested multiple antibody clones and protocols, including monoclonal (mAb) and polyclonal (pAb) antibodies.

Main Results:

  • Identified effective mAbs and pAbs for equine T-lymphocytes (CD3+), B-lymphocytes (CD79αcy+), macrophages (MAC387), neurons (NF-H+), microglia/macrophages (Iba-1+), and astrocytes (GFAP+).
  • Human and swine-derived antibodies showed high reactivity with equine FFPE tissue targets.
  • Optimized IHC protocols were developed for each validated antibody.

Conclusions:

  • A validated set of antibodies and optimized IHC protocols are now available for equine neuroinflammatory disease research.
  • These reagents facilitate detailed immunopathological analysis of equine CNS tissues.
  • The findings address the need for specific reagents in equine neuropathology.

Related Concept Videos